Reports on the medicinal properties of foods are often of interest to the general public, with the hope of finding or maintaining better health through proper nutrition. For many years, the relationship between the consumption of berries and cancer prevention has been studied in lab animals, with results from these scientific studies interpreted for their potential applications in daily life. What does current research tell us about the potency of raspberries, blueberries and other berries toward preventing cancer and can we yet issue any practical indications for humans? Dr. Gary Stoner, professor emeritus in the division of hematology and oncology within the department of internal medicine at the Ohio State University College of Medicine, joins host Dr. Cathleen Margolin to help us provide clear guidance to our patients who inquire about the nutritional value of these fruits.
A Closer Look at the Health Claims Behind Berries
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Reports on the medicinal properties of foods are often of interest to the general public, with the hope of finding or maintaining better health through proper nutrition. For many years, the relationship between the consumption of berries and cancer prevention has been studied in lab animals, with results from these scientific studies interpreted for their potential applications in daily life. What does current research tell us about the potency of raspberries, blueberries and other berries toward preventing cancer and can we yet issue any practical indications for humans? Dr. Gary Stoner, professor emeritus in the division of hematology and oncology within the department of internal medicine at the Ohio State University College of Medicine, joins host Dr. Cathleen Margolin to help us provide clear guidance to our patients who inquire about the nutritional value of these fruits.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Innovations in the Management of Hemolytic Disease of the Fetus and Newborn: The Role of the Neonatal Fc Receptor (FcRn) Pathway
IgG4-RD Case Conversations: Systemic Disease Infiltrating the Skull Base
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
Digesting IgG4-RD: An Interactive, Multidisciplinary Case Conference
Diagnosis and Management of Metastatic PDAC
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
First-line Chemotherapy Options in Metastatic PDAC
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?